Table 6 Glance over the ability of different assays in distinguishing the radiosensitivity level among breast cancer patients, BRCA1/2 mutation carriers and breast cancer patients with radiotherapy complication

BC cases vs Healthy controls

Healthy BRCA1 mutation carriers vs Healthy controls

Healthy BRCA2 mutation carriers vs Healthy controls

Healthy BRCA1/2 mutation carriers vs Non-carrier subjects from BRCA1/2 families

BC with BRCA1/2 mutation vs BC W/O BRCA1/2 mutation

BRCA2 vs BRCA1

Radiotherphy Complication